0001225208-22-002833.txt : 20220218
0001225208-22-002833.hdr.sgml : 20220218
20220218211647
ACCESSION NUMBER: 0001225208-22-002833
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220216
FILED AS OF DATE: 20220218
DATE AS OF CHANGE: 20220218
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Deal Stanley A
CENTRAL INDEX KEY: 0001690924
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-00442
FILM NUMBER: 22654676
MAIL ADDRESS:
STREET 1: C/O THE BOEING COMPANY
STREET 2: 100 RIVERSIDE PLAZA, MC 5003-1001
CITY: CHICAGO
STATE: IL
ZIP: 60606-1596
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BOEING CO
CENTRAL INDEX KEY: 0000012927
STANDARD INDUSTRIAL CLASSIFICATION: AIRCRAFT [3721]
IRS NUMBER: 910425694
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: P O BOX 3707 MS 1F 31
CITY: SEATTLE
STATE: WA
ZIP: 98124
BUSINESS PHONE: 312-544-2000
MAIL ADDRESS:
STREET 1: 100 N RIVERSIDE PLZ
CITY: CHICAGO
STATE: IL
ZIP: 60606-1596
FORMER COMPANY:
FORMER CONFORMED NAME: BOEING AIRPLANE CO
DATE OF NAME CHANGE: 19730725
4
1
doc4.xml
X0306
4
2022-02-16
0000012927
BOEING CO
BA
0001690924
Deal Stanley A
100 N. RIVERSIDE PLAZA
M/C 5003-1001
CHICAGO
IL
60606
1
EVP, Pres. & CEO, BCA
Common Stock
2022-02-16
4
A
0
12874.7470
0.0000
A
60679.2770
D
Common Stock
990.1400
I
401(k) plan
Common Stock
4319.5800
I
Career Shares
Stock Option (Right to Buy)
260.9800
2022-02-16
4
A
0
33718.0000
0.0000
A
2025-02-16
2032-02-16
Common Stock
33718.0000
33718.0000
D
Represents restricted stock units that will vest and settle in shares of the Company's common stock on a one-for-one basis on February 17, 2025.
Reflects periodic contributions to the issuer's common stock fund in the issuer's 401(k) plan. Ownership in the issuer's 401(k) plan is represented by units in the issuer's common stock fund in the plan rather than shares of common stock.
The exercise price is equal to 120% of the average of the high and the low trading prices on the date of the grant (the "Grant Date FMV"). The exercise price will be reduced to 110% of the Grant Date FMV if the issuer's total shareholder return ("TSR") over the three-year vesting period exceeds the median TSR for the peer group of companies listed in the award agreement.
The option becomes vested and exercisable in full on February 16, 2025, which is the third anniversary of the date of grant.
/s/ Dana Kumar, Attorney-in-Fact
2022-02-18